BookmarkSubscribeRSS Feed
CathyVI
Pyrite | Level 9

Hello,

Am new to this topic so I will appreciate any feedback.

I am to analyze the efficacy endpoint that include the occurrence of an infection between the last vaccination and the subsequent 168 days (2 month) and separately for the subsequent 532 (5 month) days if efficacy is shown for the initial follow-up period. The number censored are small, say < 10%, so I think the resulting bias is likely to be small and can be ignored (Please let me know any other thoughts).

Question1: I have these following dates but am not sure which ones I’ll use to calculate my survival time.

SubjectReferenceStartDate   SubjectReferenceEndDate DateofFirstStudyTreatment  DateofLastStudyTreatment  DateofEndofParticipation.

Question 2: What will my variables be for the TIME statement ?

For example:

proc lifetest data= notable;

time survtime*censor(0);

strata treat;

run;

I have created this artificial data with variable of interest to help demonstrate my idea

subjectID $ Age ArmCode $ SubjectReferenceStartDate   SubjectReferenceEndDate DateofFirstStudyTreatment  DateofLastStudyTreatment  DateofEndofParticipation Result $ VisitName $

AB123 30 Drug 2015-03-01 2017-12-01 2015-03-01 2015-06-27 2017-12-01 Negative Day 10, Dose 3

AB123 30 Drug 2015-03-01 2017-12-01 2015-03-01 2015-06-27 2017-12-01 Negative Month 1, Post-dose 3

AB123 30 Drug 2015-03-01 2017-12-01 2015-03-01 2015-06-27 2017-12-01 Positive Month 2, Post-dose 3

AB123 30 Drug 2015-03-01 2017-12-01 2015-03-01 2015-06-27 2017-12-01 Negative   Month 3, Post-dose 3

AB123  30 Drug 2015-03-01 2017-12-01 2015-03-01 2015-06-27 2017-12-01 Negative Month 4, Post-dose 3

AB123      30    Drug    2015-03-01 2017-12-01 2015-03-01 2015-06-27 2017-12-01   Positive     Month 5, Post-dose 3

AB123      30    Drug   2015-03-01 2017-12-01 2015-03-01 2015-06-27 2017-12-01   Positive     Month 6, Post-dose 3

AB123      30   Drug   2015-03-01 2017-12-01 2015-03-01 2015-06-27 2017-12-01  Positive     Month 7, Post-dose 3

CD456      35  Placebo  2015-03-01 2017-12-01 2015-03-01 2015-06-27 2017-12-01  Negative   Day 10, Dose 3

2 REPLIES 2
sbxkoenk
SAS Super FREQ

Hello,

 

I have moved your post to the "statistical procedures" board (as it is a question on survival | time-to-event analysis).

Higher probability to get a proper answer here.

 

Koen

SteveDenham
Jade | Level 19

I am confused by the day to month correspondence you present (2 months = 168 days, 5 months = 532 days).  It is unlikely to affect your analysis, but I think interpretation of results might be difficult as it looks like the two cohorts are not commensurate.

 

SteveDenham

SAS Innovate 2025: Save the Date

 SAS Innovate 2025 is scheduled for May 6-9 in Orlando, FL. Sign up to be first to learn about the agenda and registration!

Save the date!

What is ANOVA?

ANOVA, or Analysis Of Variance, is used to compare the averages or means of two or more populations to better understand how they differ. Watch this tutorial for more.

Find more tutorials on the SAS Users YouTube channel.

Discussion stats
  • 2 replies
  • 624 views
  • 0 likes
  • 3 in conversation